SCHEMBL7708926

SCHEMBL7708926

CCOC(=O)C1=Cc2ccccc2N(C)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.41
SMN1; SMN2 Q16637 4/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
TP53 P04637 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 3/20 0.40
ALDH1A1 P00352 2/20 0.40
NOTUM Q6P988 1/20 0.40
LMNA P02545 2/20 0.39
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
ACHE P22303 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12426342 0.86 TSHR (0.44) TSHRSMN1; SMN2RAB9APOLBGAA
SCHEMBL10474823 0.85 NPC1 (0.45) TSHRSMN1; SMN2NPC1RAB9ATP53
SCHEMBL7543301 0.82 GABRG2 (0.43) SMN1; SMN2ALDH1A1LMNAGABRA1GABRG2
SCHEMBL7714538 0.78 KMT2A (0.48) TSHRSMN1; SMN2TP53GAAALDH1A1
SCHEMBL7543466 0.78 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1LMNAMAPTKMT2A
SCHEMBL29433567 0.76 TSHR (0.47) TSHRSMN1; SMN2NPC1RAB9ATP53
SCHEMBL7712683 0.76 TSHR (0.47) TSHRSMN1; SMN2NPC1RAB9ATP53
SCHEMBL10472815 0.75 NPC1 (0.47) TSHRSMN1; SMN2NPC1RAB9ATP53
SCHEMBL7714827 0.73 TSHR (0.45) TSHRSMN1; SMN2NPC1RAB9APOLB
SCHEMBL7714706 0.72 TSHR (0.44) TSHRGAAALDH1A1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6369110-B1 PROPHYLACTIC AGENT FOR DISEASES CAUSED BY THE ACCELERATION OF THE SODIUM/PROTON EXCHANGE TRANSPORT SYSTEM SUMITOMO PHARMACEUTICALS COMPANY (JP) 2002-04-09 US disclosed
EP-1083166-A1 NOVEL SUBSTITUTED GUANIDINE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2001-03-14 EP disclosed